title: Radiation Recall Dermatitis With Concomitant Dabrafenib and Pazopanib Therapy.
authors.affiliation: Division of Medical Oncology, Department of Internal Medicine, Stanford University, Stanford, California.
authors.forename: Sigurdis
authors.initials: S
authors.lastname: Haraldsdottir
authors.affiliation: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus.
authors.forename: Erin
authors.initials: E
authors.lastname: Bertino
authors.affiliation: Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus.
authors.forename: Karl
authors.initials: K
authors.lastname: Haglund
authors.affiliation: Division of Dermatology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Kaffenberger
authors.affiliation: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus.
authors.forename: Manisha H
authors.initials: MH
authors.lastname: Shah
mesh_terms: D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005266:Femoral Neoplasms / Q000628:therapy; D005594:Fracture Fixation, Intramedullary; D005598:Fractures, Spontaneous / Q000628:therapy; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D007191:Indazoles; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010091:Oximes / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D011855:Radiodermatitis / Q000139:chemically induced*; D018714:Radiotherapy, Adjuvant; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D007093:Imidazoles; D007191:Indazoles; D010091:Oximes; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib; C561627:dabrafenib